Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Translational Cancer Research|September 29, 2017
The role of novel immunotherapies in non-Hodgkin lymphomaAllyson Pishko, Sunita D Nasta
Case Reports in Oncological Medicine|September 24, 2014
Waldenström macroglobulinemia in hepatitis C: case report and review of the current literatureRyan Nipp, Aaron Mitchell, Allyson Pishko, et al.
Blood Advances|October 7, 2024
Adeno-associated virus-based gene therapy for hemophilia A and B: a systematic review and meta-analysisSaarang R Deshpande, Keerthy Joseph, Jiayi Tong, et al.
Journal of Women'S Health (2002)|June 8, 2022
Sex as an Independent Risk Factor for Venous Thromboembolism in Sickle Cell Disease: A Cross-Sectional StudyAndrea H Roe, Arden McAllister, Corinne Kete, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2024
Hormone Replacement Therapy in Patients with Gynecologic Cancer and Radiation-Induced Premature Ovarian InsufficiencyAbigail Pepin, Arina Chesnokova, Allyson Pishko, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|May 4, 2024
Contraceptive Attitudes and Beliefs of Women With Sickle Cell Disease: A Qualitative StudyAndrea H Roe, Jessica Wu, Arden McAllister, et al.
Arthritis and Rheumatism|May 21, 2013
Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritisJeffrey A Dvergsten, Robert G Mueller, Patricia Griffin, et al.
Blood Advances|January 9, 2026
Pomalidomide for Hereditary Hemorrhagic Telangiectasia: After Trial Longitudinal Assessment Study (PATH-HHT ATLAS)Ellen Zhang, Raj S Kasthuri, Joseph Parambil, et al.
Blood Advances|February 20, 2026
Characteristics Associated with Clinical Response to Pomalidomide in Hereditary Hemorrhagic TelangiectasiaHanny Al-Samkari, Sonia Thomas, Derek Joseph Marsh, et al.
Pageof 2